GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Gross Margin %

Invictus MD Strategies (Invictus MD Strategies) Gross Margin % : 29.40% (As of Oct. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Invictus MD Strategies's Gross Profit for the three months ended in Oct. 2019 was $0.19 Mil. Invictus MD Strategies's Revenue for the three months ended in Oct. 2019 was $0.64 Mil. Therefore, Invictus MD Strategies's Gross Margin % for the quarter that ended in Oct. 2019 was 29.40%.


The historical rank and industry rank for Invictus MD Strategies's Gross Margin % or its related term are showing as below:


IVITF's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 46.765
* Ranked among companies with meaningful Gross Margin % only.

Invictus MD Strategies had a gross margin of 29.40% for the quarter that ended in Oct. 2019 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Invictus MD Strategies was 0.00% per year.


Invictus MD Strategies Gross Margin % Historical Data

The historical data trend for Invictus MD Strategies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Gross Margin % Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Gross Margin %
- 32.52 38.78 70.14 32.25

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.88 31.20 76.50 21.09 29.40

Competitive Comparison of Invictus MD Strategies's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Gross Margin % falls into.



Invictus MD Strategies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Invictus MD Strategies's Gross Margin for the fiscal year that ended in Jan. 2019 is calculated as

Gross Margin % (A: Jan. 2019 )=Gross Profit (A: Jan. 2019 ) / Revenue (A: Jan. 2019 )
=1.1 / 3.529
=(Revenue - Cost of Goods Sold) / Revenue
=(3.529 - 2.391) / 3.529
=32.25 %

Invictus MD Strategies's Gross Margin for the quarter that ended in Oct. 2019 is calculated as


Gross Margin % (Q: Oct. 2019 )=Gross Profit (Q: Oct. 2019 ) / Revenue (Q: Oct. 2019 )
=0.2 / 0.636
=(Revenue - Cost of Goods Sold) / Revenue
=(0.636 - 0.449) / 0.636
=29.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Invictus MD Strategies  (OTCPK:IVITF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Invictus MD Strategies had a gross margin of 29.40% for the quarter that ended in Oct. 2019 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Invictus MD Strategies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS ANNOUNCES RESIGNATIONS

By Marketwired Marketwired 12-06-2019

Invictus announces Non-Brokered Private Placement

By Marketwired Marketwired 07-03-2019

INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

By Marketwired Marketwired 10-17-2019

INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

By Marketwired Marketwired 09-24-2019

UPDATE ON ACREAGE PHARMS LTD.

By Marketwired Marketwired 06-12-2019